These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 26890764)

  • 1. Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.
    Aso E; Andrés-Benito P; Carmona M; Maldonado R; Ferrer I
    J Alzheimers Dis; 2016; 51(2):489-500. PubMed ID: 26890764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice.
    Aso E; Sánchez-Pla A; Vegas-Lozano E; Maldonado R; Ferrer I
    J Alzheimers Dis; 2015; 43(3):977-91. PubMed ID: 25125475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
    J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice.
    Cheng D; Spiro AS; Jenner AM; Garner B; Karl T
    J Alzheimers Dis; 2014; 42(4):1383-96. PubMed ID: 25024347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2014 Mar; 20(1):29-36. PubMed ID: 24722782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer's disease mouse model.
    Schmöle AC; Lundt R; Ternes S; Albayram Ö; Ulas T; Schultze JL; Bano D; Nicotera P; Alferink J; Zimmer A
    Neurobiol Aging; 2015 Feb; 36(2):710-9. PubMed ID: 25443294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AβPP/PS1 mice.
    Aso E; Juvés S; Maldonado R; Ferrer I
    J Alzheimers Dis; 2013; 35(4):847-58. PubMed ID: 23515018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology.
    Schmöle AC; Lundt R; Toporowski G; Hansen JN; Beins E; Halle A; Zimmer A
    J Alzheimers Dis; 2018; 64(2):379-392. PubMed ID: 29865078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
    Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
    J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic deletion of CB
    Aso E; Andrés-Benito P; Ferrer I
    Biochem Pharmacol; 2018 Nov; 157():210-216. PubMed ID: 30096288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of CB
    Wu J; Hocevar M; Foss JF; Bie B; Naguib M
    Eur J Pharmacol; 2017 Sep; 811():12-20. PubMed ID: 28551012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Aβ40 Levels in 12-Month-Old Male AβPPswe/PS1ΔE9 Transgenic Mice.
    Watt G; Shang K; Zieba J; Olaya J; Li H; Garner B; Karl T
    J Alzheimers Dis; 2020; 74(3):937-950. PubMed ID: 32116258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
    Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
    Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model.
    Wei L; Yang H; Xie Z; Yang S; Yang H; Zhao C; Wang P; Xu S; Miao J; Zhao B; Bi J
    J Alzheimers Dis; 2012; 30(3):531-43. PubMed ID: 22451314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
    Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
    J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.